Nuclear imaging in three dimensions: A unique tool in cancer research

Annals of Anatomy

Volumn 192, Issue 5, 2010, Pages 292-301

  Klonisch, Thomas ^a   Wark, Landon ^b   Hombach Klonisch, Sabine ^a   Mai, Sabine ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

3D nuclear imaging; Cancer; Chromosomes; Genomic instability; Nucleus; Shelterin; Telomeres

Indexed keywords

CHROMOSOME PROTEIN; LAMIN A; LAMIN B; LAMIN C; MYC PROTEIN; SHELTERIN; TELOMERIC REPEAT BINDING FACTOR 1; TELOMERIC REPEAT BINDING FACTOR 2; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ARTICLE; BILE DUCT CARCINOMA; BURKITT LYMPHOMA; CANCER RESEARCH; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CELL NUCLEUS; CHROMOSOME ANALYSIS; COMPUTER PROGRAM; DIAGNOSTIC VALUE; ENDOMETRIUM CANCER; FLUORESCENCE IN SITU HYBRIDIZATION; FLUORESCENCE MICROSCOPY; GENOMIC INSTABILITY; GLIOBLASTOMA; HEAD AND NECK CANCER; HIGH THROUGHPUT SCREENING; HODGKIN DISEASE; HUMAN; INTERPHASE; MALIGNANT NEOPLASTIC DISEASE; MICROSCOPY; NONHODGKIN LYMPHOMA; NONHUMAN; PATIENT CARE; PROGNOSIS; QUANTITATIVE ANALYSIS; TELOMERE; THREE DIMENSIONAL IMAGING; THYROID CANCER; TUMOR CELL; UTERINE CERVIX CANCER; GENETICS; NEOPLASM; PROCEDURES; RESEARCH; ULTRASTRUCTURE;

CELL NUCLEUS; HUMANS; IMAGING, THREE-DIMENSIONAL; IN SITU HYBRIDIZATION, FLUORESCENCE; MICROSCOPY, FLUORESCENCE; NEOPLASMS; RESEARCH; TELOMERE;

EID: 77956620202     PISSN: 09409602     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.aanat.2010.07.007     Document Type: Article

References (112)

1. Amiel A., Fejgin M.D., Goldberg-Bittman L., Sharoni R., Hadary R., Kitay-Cohen Y. Telomere aggregates in hepatitis C patients. Cancer Invest. 2009, 27:650-654.
2. Aoki K., Taketo M.M. Adenomatous polyposis coli (APC): a multi-functional tumor suppressor gene. J. Cell Sci. 2007, 120:3327-3335.
3. Baccarani M., Saglio G., Zaccaria A., Tura S. BCR-ABL breakpoint and prognosis in chronic myeloid leukemia. Blood 1992, 79:2499-2500.
4. Baerlocher G.M., Vulto I., de Jong G., Lansdorp P.M. Flow cytometry and FISH to measure the average length of telomeres (flow FISH). Nat. Protoc. 2006, 1:2365-2376.
5. Bai Y., Murnane J.P. Telomere instability in a human tumor cell line expressing NBS1 with mutations at sites phosphorylated by ATM. Mol. Cancer Res. 2003, 1:1058-1069.
6. Battey J., Moulding C., Taub R., Murphy W., Stewart T., Potter H., Lenoir G., Leder P. The human c-myc oncogene: structural consequences of translocation into the IgH locus in Burkitt lymphoma. Cell 1983, 34:779-787.
7. Berezney R., Coffey D.S. Nuclear protein matrix: association with newly synthesized DNA. Science 1975, 189:291-293.
8. Bilaud T., Brun C., Ancelin K., Koering C.E., Laroche T., Gilson E. Telomeric localization of TRF2, a novel human telobox protein. Nat. Genet. 1997, 17:236-239.
9. Biron-Shental T., Sukenik-Halevy R., Sharon Y., Goldberg-Bittman L., Kidron D., Fejgin M.D., Amiel A. Short telomeres may play a role in placental dysfunction in preeclampsia and intrauterine growth restriction. Am. J. Obstet. Gynecol. 2010, 202:e381-e387.
10. Boveri T. Ueber mehrpolige Mitosen als Mittel zur Analyse des Zellkerns. Verh. Phys. Med. Gesellschaft. Wuerzburg. 1902, 35:67-90.
11. Boveri T. Zur Frage der Entstehung maligner Tumoren 1914, Fischer, In. Jena.
12. Boveri T. The Origin of Malignant Tumors 1929, The Williams & Wilkens Company, Baltimore, USA. Boveri TbM (Ed.).
13. Bradshaw P.S., Stavropoulos D.J., Meyn M.S. Human telomeric protein TRF2 associates with genomic double-strand breaks as an early response to DNA damage. Nat. Genet. 2005, 37:193-197.
14. Broccoli D., Smogorzewska A., Chong L., de Lange T. Human telomeres contain two distinct Myb-related proteins, TRF1 and TRF2. Nat. Genet. 1997, 17:231-235.
15. Callen E., Surralles J. Telomere dysfunction in genome instability syndromes. Mutat. Res. 2004, 567:85-104.
16. Caporali A., Wark L., Vermolen B.J., Garini Y., Mai S. Telomeric aggregates and end-to-end chromosomal fusions require myc box II. Oncogene 2007, 26:1398-1406.
17. Celli G.B., de Lange T. DNA processing is not required for ATM-mediated telomere damage response after TRF2 deletion. Nat. Cell Biol. 2005, 7:712-718.
18. Cesare A.J., Griffith J.D. Telomeric DNA in ALT cells is characterized by free telomeric circles and heterogeneous t-loops. Mol. Cell Biol. 2004, 24:9948-9957.
19. Cesare A.J., Quinney N., Willcox S., Subramanian D., Griffith J.D. Telomere looping in P. sativum (common garden pea). Plant J. 2003, 36:271-279.
20. Chen Y., Yang Y., van Overbeek M., Donigian J.R., Baciu P., de Lange T., Lei M. A shared docking motif in TRF1 and TRF2 used for differential recruitment of telomeric proteins. Science 2008, 319:1092-1096.
21. Chong L., van Steensel B., Broccoli D., Erdjument-Bromage H., Hanish J., Tempst P., de Lange T. A human telomeric protein. Science 1995, 270:1663-1667.
22. Chuang T.C., Moshir S., Garini Y., Chuang A.Y., Young I.T., Vermolen B., van den Doel R., Mougey V., Perrin M., Braun M., Kerr P.D., Fest T., Boukamp P., Mai S. The three-dimensional organization of telomeres in the nucleus of mammalian cells. BMC Biol. 2004, 2:12.
23. Cremer T., Cremer C. Rise, fall and resurrection of chromosome territories: a historical perspective. Part II. Fall and resurrection of chromosome territories during the 1950s to 1980s. Part III. Chromosome territories and the functional nuclear architecture: experiments and models from the 1990s to the present. Eur. J. Histochem. 2006, 50:223-272.
24. Cremer T., Cremer M. Chromosome territories. Cold Spring Harb. Perspect. Biol. 2010, 2:a003889.
25. Cremer T., Cremer M., Dietzel S., Muller S., Solovei I., Fakan S. Chromosome territories - a functional nuclear landscape. Curr. Opin. Cell Biol. 2006, 18:307-316.
26. Danescu, A., DC, A., Mai, S., Hombach-Klonisch, S., 2010. Alterations in the 3D nuclear organization of telomeres - an early step in endometrial carcinoma development. Seventh Canadian Symposium on Telomeres and Telomerase, McMaster University, Ontario, Canada, May 13-16, p. 49.
27. de Lange T., 1992. Human telomeres are attached to the nuclear matrix. EMBO J. Feb;11(2): 717-724.
28. de Lange T. T-loops and the origin of telomeres. Nat. Rev. Mol. Cell Biol. 2004, 5:323-329.
29. de Lange T. Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev 2005, 19:2100-2110.
30. de Lange T. Telomere-related genome instability in cancer. Cold Spring Harb. Symp. Quant. Biol. 2005, 70:197-204.
31. Dechat T., Pfleghaar K., Sengupta K., Shimi T., Shumaker D.K., Solimando L., Goldman R.D. Nuclear lamins: major factors in the structural organization and function of the nucleus and chromatin. Genes. Dev. 2008, 22:832-853.
32. Denchi E.L. Give me a break: how telomeres suppress the DNA damage response. DNA Repair (Amst.) 2009, 8:1118-1126.
33. Denchi E.L., de Lange T. Protection of telomeres through independent control of ATM and ATR by TRF2 and POT1. Nature 2007, 448:1068-1071.
34. De Vos W.H., Hoebe R.A., Joss G.H., Haffmans W., Baatout S., Van Oostveldt P., Manders E.M. Controlled light exposure microscopy reveals dynamic telomere microterritories throughout the cell cycle. Cytometry A 2009, 75:428-439.
35. Donehower L.A., Harvey M., Slagle B.L., McArthur M.J., Montgomery C.A., Butel J.S., Bradley A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 1992, 356:215-221.
36. Fest T., Guffei A., Williams G., Silva S., Mai S. Uncoupling of genomic instability and tumorigenesis in a mouse model of Burkitt's lymphoma expressing a conditional box II-deleted Myc protein. Oncogene 2005, 24:2944-2953.
37. Friedman E.A. A multistage model for human colon carcinoma development integrating cell culture studies with pathology. Cancer Invest. 1985, 3:453-461.
38. Fukasawa K., Wiener F., Vande Woude G.F., Mai S. Genomic instability and apoptosis are frequent in p53 deficient young mice. Oncogene 1997, 15:1295-1302.
39. Gadji M., Fortin D., Tsanaclis A.M., Garini Y., Katzir N., Wienburg Y., Yan J., Klewes L., Klonisch T., Drouin R., Mai S. Three-dimensional nuclear telomere architecture is associated with differential time to progression and overall survival in glioblastoma patients. Neoplasia 2010, 12:183-191.
40. Glogowska, A., Suthiphongchai, T., Leelawat, K., Jinawath, A., Mai, S., 2010. Decreased numbers of telomeres in patients with bile duct cancer. Seventh Canadian Symposium on Telomeres and Telomerase, McMaster University, Ontario, Canada, May 13-16, p. 52.
41. Goldberg-Bittman L., Kitay-Cohen Y., Quitt M., Hadary R., Fejgin M.D., Yukla M., Amiel A. Telomere aggregates in non-Hodgkin lymphoma patients at different disease stages. Cancer Genet. Cytogenet. 2008, 184:105-108.
42. Gonzalez-Suarez I., Redwood A.B., Perkins S.M., Vermolen B., Lichtensztejin D., Grotsky D.A., Morgado-Palacin L., Gapud E.J., Sleckman B.P., Sullivan T., Sage J., Stewart C.L., Mai S., Gonzalo S. Novel roles for A-type lamins in telomere biology and the DNA damage response pathway. EMBO J. 2009, 28:2414-2427.
43. Gratias S., Rieder H., Ullmann R., Klein-Hitpass L., Schneider S., Boloni R., Kappler M., Lohmann D.R. Allelic loss in a minimal region on chromosome 16q24 is associated with vitreous seeding of retinoblastoma. Cancer Res. 2007, 67:408-416.
44. Griffith J.D., Comeau L., Rosenfield S., Stansel R.M., Bianchi A., Moss H., de Lange T. Mammalian telomeres end in a large duplex loop. Cell 1999, 97:503-514.
45. Gustafsson M.G. Surpassing the lateral resolution limit by a factor of two using structured illumination microscopy. J. Microsc. 2000, 198:82-87.
46. Haber D. Prophylactic oophorectomy to reduce the risk of ovarian and breast cancer in carriers of BRCA mutations. N. Engl. J. Med. 2002, 346:1660-1662.
47. Hadi E., Sharony R., Goldberg-Bittman L., Biron-Shental T., Fejgin M., Amiel A. Telomere aggregates in trisomy 21 amniocytes. Cancer Genet. Cytogenet. 2009, 195:23-26.
48. Helin K., Holm K., Niebuhr A., Eiberg H., Tommerup N., Hougaard S., Poulsen H.S., Spang-Thomsen M., Norgaard P. Loss of the retinoblastoma protein-related p130 protein in small cell lung carcinoma. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:6933-6938.
49. Hockemeyer D., Palm W., Else T., Daniels J.P., Takai K.K., Ye J.Z., Keegan C.E., de Lange T., Hammer G.D. Telomere protection by mammalian Pot1 requires interaction with Tpp1. Nat. Struct. Mol. Biol. 2007, 14:754-761.
50. Hofer A.C., Tran R.T., Aziz O.Z., Wright W., Novelli G., Shay J., Lewis M. Shared phenotypes among segmental progeroid syndromes suggest underlying pathways of aging. J. Gerontol. A Biol. Sci. Med. Sci. 2005, 60:10-20.
51. Houghtaling B.R., Cuttonaro L., Chang W., Smith S. A dynamic molecular link between the telomere length regulator TRF1 and the chromosome end protector TRF2. Curr. Biol. 2004, 14:1621-1631.
52. Huppi K., Volfovsky N., Mackiewicz M., Runfola T., Jones T.L., Martin S.E., Stephens R., Caplen N.J. MicroRNAs and genomic instability. Semin. Cancer Biol. 2007, 17:65-73.
53. Iwakuma T., Lozano G., Flores E.R. Li-Fraumeni syndrome: a p53 family affair. Cell Cycle 2005, 4:865-867.
54. Kaminker P.G., Kim S.H., Desprez P.Y., Campisi J. A novel form of the telomere-associated protein TIN2 localizes to the nuclear matrix. Cell Cycle 2009, 8:931-939.
55. Karlseder J., Broccoli D., Dai Y., Hardy S., de Lange T. p53-and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science 1999, 283:1321-1325.
56. Karlseder J., Hoke K., Mirzoeva O.K., Bakkenist C., Kastan M.B., Petrini J.H., de Lange T. The telomeric protein TRF2 binds the ATM kinase and can inhibit the ATM-dependent DNA damage response. PLoS Biol. 2004, 2:E240.
57. Kato M.V., Ishizaki K., Ejima Y., Kaneko A., Tanooka H., Sasaki M.S. Loss of heterozygosity on chromosome 13 and its association with delayed growth of retinoblastoma. Int. J. Cancer 1993, 54:922-926.
58. Kim H., Lee O.H., Xin H., Chen L.Y., Qin J., Chae H.K., Lin S.Y., Safari A., Liu D., Songyang Z. TRF2 functions as a protein hub and regulates telomere maintenance by recognizing specific peptide motifs. Nat. Struct. Mol. Biol. 2009, 16:372-379.
59. Kim S.H., Beausejour C., Davalos A.R., Kaminker P., Heo S.J., Campisi J. TIN2 mediates functions of TRF2 at human telomeres. J. Biol. Chem. 2004, 279:43799-43804.
60. Klonisch T., Hombach-Klonisch S., Wark L., Hoang-Vu C., Cheng S.Y., Mai S. Nuclear three-dimensional telomere imaging reveals early initiation of genomic instability in human thyroid carcinoma. Thyroid 2008, 18:S-63-S-64.
61. Knecht H., Sawan B., Lichtensztejn D., Lemieux B., Wellinger R.J., Mai S. The 3D nuclear organization of telomeres marks the transition from Hodgkin to Reed-Sternberg cells. Leukemia 2009, 23:565-573.
62. Knecht H., Sawan B., Lichtensztejn Z., Lichtensztejn D., Mai S. 3D Telomere FISH defines LMP1-expressing Reed-Sternberg cells as end-stage cells with telomere-poor 'ghost' nuclei and very short telomeres. Lab. Invest. 2010, 90:611-619.
63. Kuttler F., Mai S. Formation of non-random extrachromosomal elements during development, differentiation and oncogenesis. Semin. Cancer Biol. 2007, 17:56-64.
64. Lacoste S., Wiechec E., Dos Santos Silva A.G., Guffei A., Williams G., Lowbeer M., Benedek K., Henriksson M., Klein G., Mai S. Chromosomal rearrangements after ex vivo Epstein-Barr virus (EBV) infection of human B cells. Oncogene 2010, 29:503-515.
65. Lee J.S., John E.M., McGuire V., Felberg A., Ostrow K.L., DiCioccio R.A., Li F.P., Miron A., West D.W., Whittemore A.S. Breast and ovarian cancer in relatives of cancer patients, with and without BRCA mutations. Cancer Epidemiol. Biomarkers Prev. 2006, 15:359-363.
66. Li H., Myeroff L., Kasturi L., Krumroy L., Schwartz S., Willson J.K., Stanbridge E., Casey G., Markowitz S. Chromosomal autonomy of hMLH1 methylation in colon cancer. Oncogene 2002, 21:1443-1449.
67. Li S.B., Schwartz P.E., Lee W.H., Yang-Feng T.L. Allele loss at the retinoblastoma locus in human ovarian cancer. J. Natl. Cancer Inst. 1991, 83:637-640.
68. Louis S.F., Vermolen B.J., Garini Y., Young I.T., Guffei A., Lichtensztejn Z., Kuttler F., Chuang T.C., Moshir S., Mougey V., Chuang A.Y., Kerr P.D., Fest T., Boukamp P., Mai S. c-Myc induces chromosomal rearrangements through telomere and chromosome remodeling in the interphase nucleus. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:9613-9618.
69. Luderus M.E., van Steensel B., Chong L., Sibon O.C., Cremers F.F., de Lange T. Structure, subnuclear distribution, and nuclear matrix association of the mammalian telomeric complex. J. Cell Biol. 1996, 135:867-881.
70. Mai S. Initiation of telomere-mediated chromosomal rearrangements in cancer. J. Cell Biochem. 2010, 109:1095-1102.
71. Mai S., Garini Y. Oncogenic remodeling of the three-dimensional organization of the interphase nucleus: c-Myc induces telomeric aggregates whose formation precedes chromosomal rearrangements. Cell Cycle 2005, 4:1327-1331.
72. Mai S., Garini Y. The significance of telomeric aggregates in the interphase nuclei of tumor cells. J. Cell Biochem. 2006, 97:904-915.
73. Mai S., Imreh S. Non-random genomic instability in cancer: a fact, not an illusion. Semin. Cancer Biol. 2007, 17:1-4.
74. Meaburn K.J., Misteli T. Cell biology: chromosome territories. Nature 2007, 445:379-781.
75. Munoz-Jordan J.L., Cross G.A., de Lange T., Griffith J.D. t-loops at trypanosome telomeres. EMBO J. 2001, 20:579-588.
76. Murnane J.P. Telomeres and chromosome instability. DNA Repair (Amst.) 2006, 5:1082-1092.
77. Murti K.G., Prescott D.M. Telomeres of polytene chromosomes in a ciliated protozoan terminate in duplex DNA loops. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:14436-14439.
78. Okamoto K., Iwano T., Tachibana M., Shinkai Y. Distinct roles of TRF1 in the regulation of telomere structure and lengthening. J. Biol. Chem. 2008, 283:23981-23988.
79. Parnaik V.K. Role of nuclear lamins in nuclear organization, cellular signaling, and inherited diseases. Int. Rev. Cell Mol. Biol. 2008, 266:157-206.
80. Pignatelli M. The adenomatous polyposis coli tumour suppressor gene regulates c-MYC transcription in colon cancer cells. Gut 1999, 44:596.
81. Poon S.S., Martens U.M., Ward R.K., Lansdorp P.M. Telomere length measurements using digital fluorescence microscopy. Cytometry 1999, 36:267-278.
82. Possemato R., Timmons J.C., Bauerlein E.L., Wada N., Baldwin A., Masutomi K., Hahn W.C. Suppression of hPOT1 in diploid human cells results in an hTERT-dependent alteration of telomere length dynamics. Mol. Cancer Res. 2008, 6:1582-1593.
83. Raices M., Verdun R.E., Compton S.A., Haggblom C.I., Griffith J.D., Dillin A., Karlseder J. C. elegans telomeres contain G-strand and C-strand overhangs that are bound by distinct proteins. Cell 2008, 132:745-757.
84. Raz V., Vermolen B.J., Garini Y., Onderwater J.J., Mommaas-Kienhuis M.A., Koster A.J., Young I.T., Tanke H., Dirks R.W. The nuclear lamina promotes telomere aggregation and centromere peripheral localization during senescence of human mesenchymal stem cells. J. Cell Sci. 2008, 121:4018-4028.
85. Santibanez-Koref M.F., Birch J.M., Hartley A.L., Jones P.H., Craft A.W., Eden T., Crowther D., Kelsey A.M., Harris M. p53 germline mutations in Li-Fraumeni syndrome. Lancet 1991, 338:1490-1491.
86. Sarkar R., Guffei A., Vermolen B.J., Garini Y., Mai S. Alterations of centromere positions in nuclei of immortalized and malignant mouse lymphocytes. Cytometry A 2007, 71:386-392.
87. Schaefer L.H., Schuster D., Herz H. Generalized approach for accelerated maximum likelihood based image restoration applied to three-dimensional fluorescence microscopy. J Microsc. 2001 Nov; 204 (Pt 2): 99-107.
88. Schermelleh L., Carlton P.M., Haase S., Shao L., Winoto L., Kner P., Burke B., Cardoso M.C., Agard D.A., Gustafsson M.G., Leonhardt H., Sedat J.W. Subdiffraction multicolor imaging of the nuclear periphery with 3D structured illumination microscopy. Science 2008, 320:1332-1336.
89. Semczuk A., Marzec B., Roessner A., Jakowicki J.A., Wojcierowski J., Schneider-Stock R. Loss of heterozygosity of the retinoblastoma gene is correlated with the altered pRb expression in human endometrial cancer. Virchows Arch. 2002, 441:577-583.
90. Silva A.G., Graves H.A., Guffei A., Ricca T.I., Mortara R.A., Jasiulionis M.G., Mai S. Telomere-centromere-driven genomic instability contributes to karyotype evolution in a mouse model of melanoma. Neoplasia 2010, 12:11-19.
91. Smogorzewska A., de Lange T. Different telomere damage signaling pathways in human and mouse cells. EMBO J. 2002, 21:4338-4348.
92. Smogorzewska A., van Steensel B., Bianchi A., Oelmann S., Schaefer M.R., Schnapp G., de Lange T. Control of human telomere length by TRF1 and TRF2. Mol. Cell Biol. 2000, 20:1659-1668.
93. Stansel R.M., de Lange T., Griffith J.D. T-loop assembly in vitro involves binding of TRF2 near the 3' telomeric overhang. EMBO J. 2001, 20:5532-5540.
94. Stavropoulos D.J., Bradshaw P.S., Li X., Pasic I., Truong K., Ikura M., Ungrin M., Meyn M.S. The Bloom syndrome helicase BLM interacts with TRF2 in ALT cells and promotes telomeric DNA synthesis. Hum. Mol. Genet. 2002, 11:3135-3144.
95. Sukenik-Halevy R., Fejgin M., Kidron D., Goldberg-Bittman L., Sharony R., Biron-Shental T., Kitay-Cohen Y., Amiel A. Telomere aggregate formation in placenta specimens of pregnancies complicated with pre-eclampsia. Cancer Genet. Cytogenet. 2009, 195:27-30.
96. Takai K.K., Hooper S., Blackwood S., Gandhi R., de Lange T. In vivo stoichiometry of shelterin components. J. Biol. Chem. 2010, 285:1457-1467.
97. Tandonnet J., Clavel J., Baruchel A., Nacka F., Perel Y. Myeloid leukaemia in children with Down syndrome: report of the registry-based French experience between 1990 and 2003. Pediatr. Blood Cancer 2010, 54:927-933.
98. Taub R., Kirsch I., Morton C., Lenoir G., Swan D., Tronick S., Aaronson S., Leder P. Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells. Proc. Natl. Acad. Sci. U.S.A. 1982, 79:7837-7841.
99. Tian S.S., Faust C. A simple and precise aberrant translocation of the rat c-myc gene into the epsilon-heavy chain switch region of the IgE-producing immunocytoma, IR162. J. Biol. Chem. 1989, 264:1846-1853.
100. van Roon E.H., van Puijenbroek M., Middeldorp A., van Eijk R., de Meijer E.J., Erasmus D., Wouters K.A., van Engeland M., Oosting J., Hes F.J., Tops C.M., van Wezel T., Boer J.M., Morreau H. Early onset MSI-H colon cancer with MLH1 promoter methylation, is there a genetic predisposition?. BMC Cancer 2010, 10:180.
101. van Steensel B., de Lange T. Control of telomere length by the human telomeric protein TRF1. Nature 1997, 385:740-743.
102. Vermolen B.J., Garini Y., Mai S., Mougey V., Fest T., Chuang T.C., Chuang A.Y., Wark L., Young I.T. Characterizing the three-dimensional organization of telomeres. Cytometry A 2005, 67:144-150.
103. Wang Y., Panteleyev A.A., Owens D.M., Djabali K., Stewart C.L., Worman H.J. Epidermal expression of the truncated prelamin A causing Hutchinson-Gilford progeria syndrome: effects on keratinocytes, hair and skin. Hum. Mol. Genet. 2008, 17:2357-2369.
104. Wark, L., Hombach-Klonisch, S., Cheng, S.Y., Mai, S., Klonisch, T., 2010. Three-dimensional (3D) analysis of telomeres in thyroid tumor initiation and progression. Seventh Canadian Symposium on Telomeres and Telomerase, McMaster University, Ontario, Canada, May 13-16, p. 66.
105. Weaver B.A., Silk A.D., Montagna C., Verdier-Pinard P., Cleveland D.W. Aneuploidy acts both oncogenically and as a tumor suppressor. Cancer Cell 2007, 11:25-36.
106. Willis N.D., Cox T.R., Rahman-Casans S.F., Smits K., Przyborski S.A., van den Brandt P., van Engeland M., Weijenberg M., Wilson R.G., de Bruine A., Hutchison C.J. Lamin A/C is a risk biomarker in colorectal cancer. PLoS One 2008, 3:e2988.
107. Wright W.E., Shay J.W. Telomere biology in aging and cancer. J. Am. Geriatr. Soc. 2005, 53:S292-294.
108. Xin H., Liu D., Wan M., Safari A., Kim H., Sun W., O'Connor M.S., Songyang Z. TPP1 is a homologue of ciliate TEBP-beta and interacts with POT1 to recruit telomerase. Nature 2007, 445:559-562.
109. Ye J.Z., de Lange T. TIN2 is a tankyrase 1 PARP modulator in the TRF1 telomere length control complex. Nat. Genet. 2004, 36:618-623.
110. Zaccaria A., Tassinari A., Testoni N., Lauria F., Tura S., Algeri R., Guerrasio A., Rosso C., Saglio G. Alternative BCR/ABL transcripts in chronic myeloid leukemia. Blood 1990, 76:1663-1665.
111. Zhong Z., Shiue L., Kaplan S., de Lange T. A mammalian factor that binds telomeric TTAGGG repeats in vitro. Mol. Cell Biol. 1992, 12:4834-4843.
112. Zwaan C.M., Reinhardt D., Hitzler J., Vyas P. Acute leukemias in children with Down syndrome. Hematol. Oncol. Clin. North Am. 2010, 24:19-34.